MRZXJALNVFXSJF-SIKLNZKXSA-N
C31H24F6N6O5 — CID 146614470
Data last refreshed: (MolForge compound catalog, from PubChem)
About MRZXJALNVFXSJF-SIKLNZKXSA-N
MRZXJALNVFXSJF-SIKLNZKXSA-N (PubChem CID 146614470) has the molecular formula C31H24F6N6O5 and a molecular weight of 674.56 g/mol. Its IUPAC name is (2S)-3-[8-(1-methyl-2,4-dioxopyrido[3,4-d]pyrimidin-3-yl)quinolin-5-yl]-2-[[2,3,6-trifluoro-4-[[(2R)-1,1,1-trifluorobutan-2-yl]amino]benzoyl]amino]propanoic acid.
Molecular Properties
| Compound Name | MRZXJALNVFXSJF-SIKLNZKXSA-N |
|---|---|
| PubChem CID | 146614470 |
| Molecular Formula | C31H24F6N6O5 |
| Molecular Weight | 674.56 g/mol |
| Exact Mass | 674.17 |
| IUPAC Name | (2S)-3-[8-(1-methyl-2,4-dioxopyrido[3,4-d]pyrimidin-3-yl)quinolin-5-yl]-2-[[2,3,6-trifluoro-4-[[(2R)-1,1,1-trifluorobutan-2-yl]amino]benzoyl]amino]propanoic acid |
| SMILES | CC[C@@H](Nc1cc(F)c(C(=O)N[C@@H](Cc2ccc(-n3c(=O)c4ccncc4n(C)c3=O)c3ncccc23)C(=O)O)c(F)c1F)C(F)(F)F |
| InChI | InChI=1S/C31H24F6N6O5/c1-3-22(31(35,36)37)40-18-12-17(32)23(25(34)24(18)33)27(44)41-19(29(46)47)11-14-6-7-20(26-15(14)5-4-9-39-26)43-28(45)16-8-10-38-13-21(16)42(2)30(43)48/h4-10,12-13,19,22,40H,3,11H2,1-2H3,(H,41,44)(H,46,47)/t19-,22+/m0/s1 |
| InChIKey | MRZXJALNVFXSJF-SIKLNZKXSA-N |
| XLogP | 4.23 |
| TPSA | 148.21 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 674.56 |
| LogP ≤ 5 | 4.23 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146614470 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.